Furthermore, within an immune and iron-death-related risk score model for ovarian cancer patients developed by Chunyan Wei et al., PPP3CA has been identified as a prognostic factor aiding in predicting patient response to immunotherapy [29]. This evidence concerns the gene PPP3CA and ovarian carcinoma.